Shopping Cart
Remove All
Your shopping cart is currently empty
Bufexamac (Bufexamic acid) is a COX inhibitor for IFN-α release with anti-inflammatory, analgesic, and antipyretic action.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | $29 | In Stock | In Stock | |
| 200 mg | $38 | In Stock | In Stock | |
| 500 mg | $52 | - | In Stock | |
| 1 g | $75 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock | In Stock |
| Description | Bufexamac (Bufexamic acid) is a COX inhibitor for IFN-α release with anti-inflammatory, analgesic, and antipyretic action. |
| Targets&IC50 | HDAC3:341 μM (Kd app), HDAC6:10.7 μM (Kd app), HDAC8:235 μM (Kd app), HDAC10:12.3 μM (Kd app), IFN-α:8.9 μM |
| In vitro | Bufexamac is a specific inhibitor of class IIB histone deacetylases (HDAC6 and HDAC10). Treatment of peripheral blood mononuclear cells with bufexamac inhibits the secretion of IFN-α. [1] Bufexamac is a frequent and relevant contact sensitizer. Bufexamac is a non-steroidal anti-inflammatory drug. [2] |
| Synonyms | Bufexamic acid |
| Molecular Weight | 223.27 |
| Formula | C12H17NO3 |
| Cas No. | 2438-72-4 |
| Smiles | C(C(NO)=O)C1=CC=C(OCCCC)C=C1 |
| Relative Density. | 1.1223 g/cm3 (Estimated) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 3 mg/mL (13.44 mM), Sonication is recommended. DMSO: 70 mg/mL (313.52 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.